Lilly Begins Sales of Jentadueto, a Combo Drug for Type 2s

| Mar 10, 2012

Eli Lilly and Company has begun US sales of Jentadueto, a drug for type 2 diabetes that combines Tradjenta and metformin. The drug, in tablet form, is taken twice daily and is available in three prescription strengths.

Tradjenta (linagliptin) is a DPP-4 inhibitor that regulates insulin levels. The drug was introduced less than a year ago to the US market.

Metformin, which regulates the liver's glucose production, is an older standby drug that physicians often prescribe as the first drug therapy for recently diagnosed type 2s.

Lilly developed Tradjenta in conjunction with German drug maker Boehringer Ingelheim.

Click Here To View Or Post Comments

Categories: Boehringer Ingelheim, Diabetes, Diabetes, DPP-4 Inhibitor, Drug Therapy, Eli Lilly, Glucose Production, Insulin Levels, Jentadueto, Metformin, Tradjenta, Type 2 Diabetes, Type 2 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Mar 10, 2012

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.